KJ

Active Director Director DIN 10904069
DIN 10904069 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalp Jain

Data last updated:

Kalp Jain is a Director at Phytocraft Sciences Private Limited (since 2025) and Additional Director at Orange Biochem Private Limited (since 2025). The companies operate in Pharma.

DIN 10904069
Primary Designation Director
Industry Pharma
First Appointment 13 Jan 2025
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phytocraft Sciences Private Limited U75000MP2025PTC078256
Director12 Aug 20252025Active
Orange Biochem Private Limited U51909MP2016PTC041607
Additional Director13 Jan 20252016Active

Board colleagues of Kalp Jain

Directorship timeline

Open interactive timeline →
Phytocraft Sciences Private Limited
Orange Biochem Private Limited
Premium access

Shareholding and investment profile for Kalp Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalp Jain

Kalp Jain currently holds 2 directorships: Phytocraft Sciences Private Limited (Director, since 12 Aug 2025); Orange Biochem Private Limited (Additional Director, since 13 Jan 2025).

Kalp Jain was first appointed on 13 Jan 2025 as Additional Director at Orange Biochem Private Limited.

The current boards of Kalp Jain's companies include Neeta Jain (Phytocraft Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available